ADVERTISEMENT

Laurus Labs Forays Into Biotech Segment Via Acquisition

Laurus Labs Forays Into Biotech Segment Via Acquisition

Laurus Labs Forays Into Biotech Segment Via Acquisition
Laurus Labs Forays Into Biotech Segment Via Acquisition
Laurus Labs forays into broader biologics & biotechnology segments by acquiring Richcore Lifesciences. Founder & CEO Satyanarayana Chava feels this acquisition will add 'fourth lever of growth' & fast-track its biotech ambitions.